Guijarro, L.G.; de Castro-MartÃnez, P.; Chaparro, M.; Acero-Sanz, J.; de León, D.; Guerra, I.; Iborra, M.; Cabriada, J.L.; Bujanda, L.; Alba, C.;
et al. Comparative Efficacy and Immunogenicity of Infliximab and Adalimumab in Crohn’s Disease: A Prospective Cohort Study. Medicina 2025, 61, 2165.
https://doi.org/10.3390/medicina61122165
AMA Style
Guijarro LG, de Castro-MartÃnez P, Chaparro M, Acero-Sanz J, de León D, Guerra I, Iborra M, Cabriada JL, Bujanda L, Alba C,
et al. Comparative Efficacy and Immunogenicity of Infliximab and Adalimumab in Crohn’s Disease: A Prospective Cohort Study. Medicina. 2025; 61(12):2165.
https://doi.org/10.3390/medicina61122165
Chicago/Turabian Style
Guijarro, Luis G., Patricia de Castro-MartÃnez, MarÃa Chaparro, Julio Acero-Sanz, Diego de León, Iván Guerra, Marisa Iborra, José Luis Cabriada, Luis Bujanda, Cristina Alba,
and et al. 2025. "Comparative Efficacy and Immunogenicity of Infliximab and Adalimumab in Crohn’s Disease: A Prospective Cohort Study" Medicina 61, no. 12: 2165.
https://doi.org/10.3390/medicina61122165
APA Style
Guijarro, L. G., de Castro-MartÃnez, P., Chaparro, M., Acero-Sanz, J., de León, D., Guerra, I., Iborra, M., Cabriada, J. L., Bujanda, L., Alba, C., GarcÃa-Sánchez, V., MarÃn-Jiménez, I., Barreiro-de Acosta, M., Vera, I., MartÃn-Arranz, M. D., Mesonero, F., Sempere, L., Gomollón, F., Hinojosa, J.,
... Ortega, M. A., on behalf of the PREDICROHN Study Group from GETECCU.
(2025). Comparative Efficacy and Immunogenicity of Infliximab and Adalimumab in Crohn’s Disease: A Prospective Cohort Study. Medicina, 61(12), 2165.
https://doi.org/10.3390/medicina61122165
